Frontiers in Immunology (Aug 2022)

The relevance of complement in pemphigoid diseases: A critical appraisal

  • Cristian Papara,
  • Cristian Papara,
  • Christian M. Karsten,
  • Hideyuki Ujiie,
  • Enno Schmidt,
  • Enno Schmidt,
  • Leon F. Schmidt-Jiménez,
  • Adrian Baican,
  • Patricia C. Freire,
  • Kentaro Izumi,
  • Katja Bieber,
  • Matthias Peipp,
  • Admar Verschoor,
  • Admar Verschoor,
  • Ralf J. Ludwig,
  • Ralf J. Ludwig,
  • Jörg Köhl,
  • Jörg Köhl,
  • Detlef Zillikens,
  • Christoph M. Hammers,
  • Christoph M. Hammers

DOI
https://doi.org/10.3389/fimmu.2022.973702
Journal volume & issue
Vol. 13

Abstract

Read online

Pemphigoid diseases are autoimmune chronic inflammatory skin diseases, which are characterized by blistering of the skin and/or mucous membranes, and circulating and tissue-bound autoantibodies. The well-established pathomechanisms comprise autoantibodies targeting various structural proteins located at the dermal-epidermal junction, leading to complement factor binding and activation. Several effector cells are thus attracted and activated, which in turn inflict characteristic tissue damage and subepidermal blistering. Moreover, the detection of linear complement deposits in the skin is a diagnostic hallmark of all pemphigoid diseases. However, recent studies showed that blistering might also occur independently of complement. This review reassesses the importance of complement in pemphigoid diseases based on current research by contrasting and contextualizing data from in vitro, murine and human studies.

Keywords